Rivaroxaban Viatris (previously Rivaroxaban Mylan) Euroopan unioni - suomi - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - rivaroksabaani - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitromboottiset aineet - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Neurontin 300 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

neurontin 300 mg kapseli, kova

upjohn eesv - gabapentin - kapseli, kova - 300 mg - gabapentiini

Neurontin 400 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

neurontin 400 mg kapseli, kova

upjohn eesv - gabapentin - kapseli, kova - 400 mg - gabapentiini

Celebra 100 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celebra 100 mg kapseli, kova

upjohn eesv - celecoxib - kapseli, kova - 100 mg - selekoksibi

Celebra 200 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

celebra 200 mg kapseli, kova

upjohn eesv - celecoxib - kapseli, kova - 200 mg - selekoksibi

Zeldox 20 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

zeldox 20 mg kapseli, kova

upjohn eesv - ziprasidone hydrochloride monohydrate - kapseli, kova - 20 mg - tsiprasidoni

Zeldox 40 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

zeldox 40 mg kapseli, kova

upjohn eesv - ziprasidone hydrochloride monohydrate - kapseli, kova - 40 mg - tsiprasidoni

Zeldox 60 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

zeldox 60 mg kapseli, kova

upjohn eesv - ziprasidone hydrochloride monohydrate - kapseli, kova - 60 mg - tsiprasidoni

Zeldox 80 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

zeldox 80 mg kapseli, kova

upjohn eesv - ziprasidone hydrochloride monohydrate - kapseli, kova - 80 mg - tsiprasidoni

Tolterodin Viatris 2 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

tolterodin viatris 2 mg tabletti, kalvopäällysteinen

upjohn eesv - tolterodine tartrate - tabletti, kalvopäällysteinen - 2 mg - tolterodiini